University of New Mexico
Albuquerque, New Mexico, 87131-0001, United States
NCT Number: NCT04401943
This research is being done to evaluate if an online fatigue intervention program will decrease fatigue, pain and increase confidence managing fatigue and being able to do daily tasks. This study involves competing a series of questionnaires before and after the intervention , and attending and participating in the online videoconference fatigue program for 1 1/2 hour meetings each week over a 6-week period of time.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Albuquerque, New Mexico, 87131-0001, United States
If eligible and give consent, participants will be asked to complete 2 online questionnaires. The first questionnaire asks basic information such as your age, gender, educational level, and amount of time diagnosed with systemic sclerosis. The second questionnaire asks about your disease symptoms.
You will also be asked to complete questionnaires about your fatigue, pain, mood, confidence in managing your disease and performing daily tasks, and knowledge and use of energy saving techniques.
Once you compete the questionnaires, you will be asked to compete a survey about times and days you would be available to attend the online videoconference fatigue program meeting over a 6 week period of time.
Once the time and dates for the fatigue program are scheduled, you will be expected to attend and take part (using visual and audio) in each 1 ½ hour meeting for 6 weeks online.
The fatigue program includes information on causes of fatigue, ways to protect joint and save energy, ways to manage stress, pain, good eating habits, and exercise. Outside of meetings, you will also be expected to do any "homework" assignments in between the group meetings such as setting goals and doing activities to reach your goals.
At the end of the 6 weeks, you will be asked to complete the same questionnaires you did at the beginning of the study regarding, fatigue, pain, and ability to perform daily tasks. You will also be asked to complete an evaluation of the course.
3 months later, you will be asked to take part in a 45 minute telephone interview to talk about your fatigue and how you are using the ideas from the program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
on line teleconferencing fatigue intervention for 6 weeks on causes of fatigue, ways to protect joint and save energy, ways to manage stress, pain, good eating habits, and exercise.
Time frame: baseline, 6 weeks
self report of impact of fatigue on physical, cognitive and psychosocial functioning
Time frame: baseline, 6 weeks
Measures four subjective domains of fatigue: degree and severity, amount of distress it causes, timing, and degree to which fatigue interferes with the activities of daily living
Time frame: baseline, 6 weeks
Measures anxiety and depression
Time frame: baseline, 6 weeks
Measures participants' confidence in managing symptoms so as not to interfere with the activities they perform in day to day life.
Time frame: baseline, 6 weeks
Measures participants' confidence in their ability to use energy conservation strategies
Time frame: 6 weeks
Measures people's use of energy conservation strategies
University of New Mexico
Other
Pilot Study of an Online Fatigue Intervention Program for People With Scleroderma
Acronym: FAME-ISS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04301596
Connective Tissue Diseases, Scleroderma, Systemic
Montpellier, France
View Trial DetailsNCT07012655
Connective Tissue Diseases, Scleroderma, Systemic
Asyut, Egypt
View Trial DetailsNCT01395732
Connective Tissue Diseases, Digital Ulcers
Amsterdam, Netherlands
View Trial DetailsNCT04995588
Connective Tissue Diseases, Scleroderma, Systemic
Poitiers, France
View Trial Details